Status:
COMPLETED
National Survey on Asthma
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
Eligibility Criteria
Inclusion
- A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
- Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.
Exclusion
- Patient with a cardiac disease (congestive heart failure, coronary artery disease)
- Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
1704 Patients enrolled
Trial Details
Trial ID
NCT00770250
Start Date
September 1 2008
End Date
March 1 2009
Last Update
December 2 2010
Active Locations (905)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbeville, France
2
Research Site
Ablon-sur-Seine, France
3
Research Site
Agneaux, France
4
Research Site
Agon-Coutainville, France